1. Home
  2. CRSR vs IMCR Comparison

CRSR vs IMCR Comparison

Compare CRSR & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Corsair Gaming Inc.

CRSR

Corsair Gaming Inc.

HOLD

Current Price

$8.41

Market Cap

1.3B

Sector

Technology

ML Signal

HOLD

IMCR

Immunocore Holdings plc

HOLD

Current Price

$30.58

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRSR
IMCR
Founded
1994
2008
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Computer Manufacturing
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.4B
IPO Year
2020
2016

Fundamental Metrics

Financial Performance
Metric
CRSR
IMCR
Price
$8.41
$30.58
Analyst Decision
Buy
Buy
Analyst Count
7
10
Target Price
$8.50
$66.33
AVG Volume (30 Days)
4.0M
556.7K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
87.37
30.39
EPS
0.11
0.25
Revenue
$1,472,480,000.00
$249,428,000.00
Revenue This Year
N/A
$14.57
Revenue Next Year
$6.90
$8.21
P/E Ratio
$80.00
$122.16
Revenue Growth
11.86
43.05
52 Week Low
$4.48
$27.56
52 Week High
$13.10
$40.71

Technical Indicators

Market Signals
Indicator
CRSR
IMCR
Relative Strength Index (RSI) 46.88 61.86
Support Level $8.18 $27.66
Resistance Level $8.44 $31.56
Average True Range (ATR) 0.53 1.12
MACD -0.15 0.28
Stochastic Oscillator 22.10 73.84

Price Performance

Historical Comparison
CRSR
IMCR

About CRSR Corsair Gaming Inc.

Corsair Gaming Inc is engaged in the business of providing high-performance gear for gamers and content creators. The product portfolio includes Cases, Keyboards, Mice, Headsets, Power Supplies, Gaming Computers, Gaming Chairs, Mousepads, and other related products. The company operates in two segments namely, Gamer and Creator peripherals, which is the key revenue-generating segment; and Gaming Components and Systems. Geographically, the group derives revenue from the United States (U.S.), Americas (excluding U.S.) , Europe and the Middle East, and the Asia Pacific, of which maximum revenue is generated from United States (U.S.).

About IMCR Immunocore Holdings plc

Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.

Share on Social Networks: